Form 4: Insider Sells Worthington Enterprises Shares
Insider Transaction Filing
James R. Bowes, President - Building Products at Worthington Enterprises, Inc., reported a transaction involving the sale of 562 common shares.
Summary
- James R. Bowes, President - Building Products for Worthington Enterprises, Inc., engaged in a transaction on June 30, 2026.
- The transaction involved the disposition of 562 common shares.
- The sale price was $53.76 per share.
- Following this transaction, Mr. Bowes beneficially owns 19,385 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction without additional context on the reasons for the sale or broader company performance.
Negatives
- An insider, James R. Bowes, sold a portion of his holdings in Worthington Enterprises, Inc.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal significant shifts in company strategy or performance. The sale by a high-level executive could be for personal financial planning or diversification, but it is a data point for investors to consider.
Stakeholder Impact
- Shareholders may view insider selling with caution, although the reasons for the sale are not specified in the filing.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Transaction Date |
| 07/01/2026 | Date of Report |
Keywords
Worthington Enterprises, Insider Transaction, Form 4, Common Shares, Securities Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.